Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction

QR Code

Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction

Aim. То assess the effects of an anti-ischemic medication trimetazidine on necrosis area size, lipid peroxidation (LPO) and membrane phosphohpids in thrombolytic therapy (ТLТ) of acute myocardial infarction (AMI).Material and methods. The study included 79 AMI patients. Coronary artery recanalisatio...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. Yu. Rebrova, S. A. Afanasyev, V. A. Perchatkin, I. V. Maksimov, V. A. Markov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2009-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	acute myocardial infarction thrombolytic reperfusion upid peroxidation phospholipids trimetazidine
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1751
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
by: G. P. Ishmurzin, et al.
Published: (2010-12-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

Trimetazidine effects on mitochondria energetic activity
by: S. V. Eliseeva, et al.
Published: (2008-12-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

PHARMACOINTERVENTIONAL TACTICS OF MYOCARDIAL INFARCTION TREATMENT
by: A. P. Golikov, et al.
Published: (2016-03-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Clinical effectiveness of long-term trimetazidine MB therapy in patients with cardio-respiratory disease (the results of an open, prospective multi-centre study)
by: N. M. Kolomoets, et al.
Published: (2009-12-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

Pathogenesis and clinical significance of reperfusion arrhythmias in acute myocardial infarctio
by: V. E. Oleynikov, et al.
Published: (2024-10-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Diagnosis and Correction of Impaired Lipid Peroxidation in Terminal States: Experimental Study
by: A. S. Razumov, et al.
Published: (2006-12-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

Non-invasive assessment of thrombolysis results in acute myocardial infarction: electrocardiogram dynamics of ST segment elevation and T wave
by: L. L. Berstein
Published: (2007-12-01)

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict
by: Z. Yu. Shakhbiyeva, et al.
Published: (2019-03-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
by: V. V. Kalyuzhin, et al.
Published: (2002-03-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Treatment of venous thromboembolisms using a wireless-powered thrombolytic filter
by: Nolan G. Schwarz, et al.
Published: (2025-04-01)

Perftoran therapy perspectives in reperfusion syndrome prevention among acute myocardial infarction patients
by: S. S. Shuvalov, et al.
Published: (2006-08-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
by: I. S. Yavelov
Published: (2009-12-01)

Systemic Thrombolytic Therapy for Ischemic Stroke in the Course of Anticoagulants
by: L. Kh.-B. Akhmatkhanova, et al.
Published: (2021-11-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

THE USAGE OF TRIMETAZIDINE AND SULODEXIL TO PREVENT TRANSFORMATION OF A NON-Q MI INTO A Q-MI
by: A. A. Abdullaev, et al.
Published: (2001-10-01)

N-aldehyde-modified phosphatidylethanolamines generated by lipid peroxidation are robust substrates of N-acyl phosphatidylethanolamine phospholipase D
by: Reza Fadaei, et al.
Published: (2025-07-01)

The Efficacy of Thrombolytic Therapy in Inferior Myocardial Infarction with Damage to the Right Ventricular
by: E. S. Mazur, et al.
Published: (2021-05-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
by: E. V. Bochkareva, et al.
Published: (2012-08-01)

Thrombolytic Therapy in Normotensive Patients with Pulmonary Embolism (Data from the Retrospective Study)
by: N. A. Сherepanova, et al.
Published: (2020-11-01)